| Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619) |
|---|
| 02/26/2004 | WO2004016596A1 Condensed heterocyclic compounds as pde-iv inhibitors for the treatment of inflammatory and allergic disorders |
| 02/26/2004 | WO2004016581A1 Processes for the preparation of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile |
| 02/26/2004 | WO2004016271A1 Pyrimidones as antiviral agents |
| 02/26/2004 | WO2003101444A8 Diarylurea compounds and derivatives as chk-1 inhibitors for the treatment of cancer |
| 02/26/2004 | WO2003099211A3 Mitotic kinesin inhibitors |
| 02/26/2004 | WO2003039549A8 Selective antibacterial agents |
| 02/26/2004 | WO2003027110A3 Process for preparing 2-(4-pyridyl) amino-6-dialkyloxyphenyl-pyrido [2,3-d]pyrimidin-7-ones |
| 02/26/2004 | WO2002098869A3 1,4-disubstituted benzo-fused cycloalkyl urea compounds |
| 02/26/2004 | WO2002066672A3 Treatment of cns disorders using d-amino acid oxidase and d-aspartate oxidase antagonists |
| 02/26/2004 | US20040039201 Functionalized compositions for improved immobilization |
| 02/26/2004 | US20040039040 Urea derivative and adhesive-molecule inhibitor containing the same as active ingredient |
| 02/26/2004 | US20040039034 Hydroxypropyl amides for the treatment of Alzheimer's disease |
| 02/26/2004 | US20040039006 (2S)-2-(Adamantan-1-ylmethoxycarbonylamino)-3-(4-(2-(1,4,5,6-tetrahydropyrimidin-2-ylcarbamoyl)ethyl)benzoylamino)propionic acid isopropyl ester, its preparation and its use |
| 02/26/2004 | US20040039005 HIV replication inhibiting pyrimidines |
| 02/26/2004 | US20040039002 6,7-Dimethoxyquinazolines and therapeutic use thereof |
| 02/26/2004 | US20040039001 2-guanidino-4-aryl-quinazoline |
| 02/26/2004 | US20040039000 6-aminofuro(2,3-d)pyrimidines and 6-aminopyrrolo(2,3-d) pyrimidines useful in treating cancer, and secondary infections caused by Pneumocystis carinii and Toxoplasmosis gondii |
| 02/26/2004 | US20040038994 Pyrimidine fused bicyclic metalloproteinase inhibitors |
| 02/26/2004 | US20040038976 S,N-diarylsulfonamide derivatives; treating inflammatory diseases such as Celiac's disease, Crohn's disease or colitis. |
| 02/26/2004 | US20040038969 Substituted aminopyrimidines and aminopyridazines; analgesics particularly for migraines, neuropathic pain and associated hyperalgesia and allodynia; antiinflammatory agents; treating asthma, gastrointestinal disorders, etc. |
| 02/25/2004 | EP1391952A2 Salts of pentacyclic or tetrapentaline derived anions, and their uses as ionic conductive materials |
| 02/25/2004 | EP1391454A1 Substituted benzamide compounds with antihypertensive activity |
| 02/25/2004 | EP1391450A1 N-(heterocycle-methyl)alkylamine derivative, process for producing the same, and bactericide |
| 02/25/2004 | EP1391206A1 Pharmaceutical compositions comprising arsenic for the treatment of lymphoma |
| 02/25/2004 | EP1390352A1 Pyrimidine derivatives |
| 02/25/2004 | EP1390351A1 Pyrimidine derivatives useful as selective cox-2 inhibitors |
| 02/25/2004 | EP1390350A1 Novel compounds |
| 02/25/2004 | EP1390340A1 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 02/25/2004 | EP1211246B1 Pyrimidine derivatives and herbicides containing the same |
| 02/25/2004 | EP1165064B1 Novel inhibitors of formation of advanced glycation endproducts (age's) |
| 02/25/2004 | EP1005446B1 N-aroylphenylalanine derivatives |
| 02/25/2004 | CN1478085A ABCA-1 elevating compounds against coronary artery disease or atherosclerosis |
| 02/25/2004 | CN1478082A Pyrimidine compounds and their use |
| 02/25/2004 | CN1478078A Nitrogenous aromatic ring compounds |
| 02/25/2004 | CN1477089A Substituted dicyclohexylalkyl diphenyl derivative with good low-tomp, mutual solubility, its preparation and application |
| 02/25/2004 | CN1139577C Improved process for preparation of unsymmetrical 4,6-bis(aryloxy) pyrimidine compounds |
| 02/24/2004 | US6696487 Fungicidal phenyl(thio)urea and phenyl(thio)carbamate derivatives |
| 02/24/2004 | US6696482 Formulations for hydrophobic pharmaceutical agents |
| 02/24/2004 | US6696472 Substituted N-phenoxy-N-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity |
| 02/24/2004 | US6696456 Carbocyclic acids and salts such as (2s,3r)-3-ethylsulfanyl-2-(4'-fluoro-biphenyl-4-sulfonylamino)-3- phenylpropionic acid, used as metalloenzyme antagonists for the prophylaxis of degenerative joint disease and as wound healing agents |
| 02/24/2004 | US6696455 Nitrogen compounds such as 6-chloro-2-methyl-4-oxo-pyrido (3,2-d)pyrimidine used as anticarcinogenic agents and/or for prophylaxis of infections caused by pneumocystis or toxoplasma |
| 02/24/2004 | US6696452 Glycogen synthase kinase-3 and aurora-2 a serine/threonine protein kinase inhibitors; antidiabetic and anticancer agents and alzheimer's disease treatments |
| 02/24/2004 | US6696451 Dihydropyrimidines |
| 02/24/2004 | US6696445 Neuropeptide y receptor antagonists comprising heterocyclic nitrogen compounds and/or prodrugs used for prophylaxis of eating and cardiovascular disorders |
| 02/24/2004 | US6696442 Carbocyclic and heterocyclic substituted semicarbazones and thiosemicarbazones and the use thereof |
| 02/24/2004 | US6696435 For treating atherosclerosis, other coronary artery diseases; 3-((3-(3-trifluoromethoxyphenoxy)phenyl)((3-(1,1,2,2-tetrafluoroethoxy) -phenyl)methyl) amino)-1,1,1-trifluoro-2-propanol for example |
| 02/19/2004 | WO2004014916A1 Pyrimidine fused bicyclic metalloproteinase inhibitors |
| 02/19/2004 | WO2004014873A1 4-substituted quinazoline-8-carboxyamide derivative and pharmaceutically acceptable addition salt thereof |
| 02/19/2004 | WO2004014872A1 Process for preparing the calcium salt of rosuvastatin |
| 02/19/2004 | WO2004014871A1 Vanilloid receptor ligands and their use in treatments |
| 02/19/2004 | WO2004014870A1 Fluorinated phenyl-naphthalenyl-urea compounds as inhibitors of cytokines involved in inflammatory processes |
| 02/19/2004 | WO2004014869A2 5,6-fused 3,4-dihydropyrimidine-2-one derivatives as matrix metalloproteinase inhibitors |
| 02/19/2004 | WO2004014868A2 Pyrimidine-2,4-dione derivatives as matrix metalloproteinase inhibitors |
| 02/19/2004 | WO2004014867A2 Matrix metalloproteinase inhibitors and methods for identification of lead compounds |
| 02/19/2004 | WO2004014847A1 Mcp-1 receptor antagonists and method of use thereof |
| 02/19/2004 | WO2004014844A2 Aryl and heteroaryl compounds and methods to modulate coagulation |
| 02/19/2004 | WO2004014825A1 Cannabinoid receptor ligands |
| 02/19/2004 | WO2004014384A2 Cyclic compounds containing zinc binding groups as matrix metalloproteinase inhibitors |
| 02/19/2004 | WO2004014381A2 Matrix metalloproteinase inhibitors and methods for identification of lead compounds |
| 02/19/2004 | WO2003027234A9 Small organic molecule regulators of cell proliferation |
| 02/19/2004 | US20040034251 Such as 2-(4,6-dimethoxypyrimidine-2-ylcarbonyl)acetanilide; for use as intermediate in production of agricultural chemicals and medicines |
| 02/19/2004 | US20040034242 Compounds containing a specific branched chain end terminal group, which is isopropyl, sec.-butyl, or tert.-butyl; a polar leading group, and long chain aliphatic, non-cyclic, saturated or nonsaturated linking groups |
| 02/19/2004 | US20040034190 Preparation of supramolecular polymers by copolymerization of monomers containing quadruple hydrogen bonding units with regular monomers |
| 02/19/2004 | US20040034104 2,2-Diphenylbutanamide derivatives and medicines containing the same |
| 02/19/2004 | US20040034084 Side effect reduction; for treatment of AIDS, cancer and arthritis |
| 02/19/2004 | US20040034076 Such as methyl-3-azido-2-((4,6-dimethoxy-2-pyrimidinyl)oxy) 3,3-diphenylpropionate; for treatment of high blood pressure |
| 02/19/2004 | US20040034048 Didepsipeptide-based endoparasiticides, new didepsipeptides and process for preparing the same |
| 02/19/2004 | US20040034044 Quinazoline derivatives and drugs |
| 02/19/2004 | US20040034043 Positively-charged peptide nucleic acid analogs with improved properties |
| 02/19/2004 | US20040034034 Novel piperazine derivatives |
| 02/19/2004 | US20040034032 Quinoline and quinazoline compounds useful in therapy |
| 02/19/2004 | US20040034025 Having a high residual activity, greater activity at lower application rates, curative activity, and a broader spectrum of efficacy; heterocyclic aromatic amides having a hydroxy group adjacent to the amide functionality |
| 02/19/2004 | US20040034022 Polymorphic forms/hydrates of n-[4-(3-chloro-4-fluorophenylamino)-7-(3-morpholin-4-ylpropoxy)-quinazolin-6-yl]-acrylamide dihydrochloride |
| 02/19/2004 | US20040034018 2-amino-trihydroindole or tetrahydronapthalene-2-yl derivatives, useful for disease state associated with smooth muscle disorders, such as gastrointestinal and urogenital disorders |
| 02/19/2004 | CA2497656A1 Pyrimidine-2,4-dione derivatives as matrix metalloproteinase inhibitors |
| 02/19/2004 | CA2495067A1 Mcp-1 receptor antagonists and method of use thereof |
| 02/19/2004 | CA2494827A1 Cannabinoid receptor ligands |
| 02/19/2004 | CA2494824A1 Fluorinated phenyl-naphthalenyl-urea compounds as inhibitors of cytokines involved in inflammatory processes |
| 02/19/2004 | CA2493008A1 Aryl and heteroaryl compounds and methods to modulate coagulation |
| 02/18/2004 | EP1389461A1 Pyrimidones with antiviral properties |
| 02/18/2004 | EP1389205A1 Quinazoline and quinazoline-like compounds for the treatment of integrin-mediated disorders |
| 02/18/2004 | EP1389194A2 Inhibitors of bace |
| 02/18/2004 | EP1389189A2 Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues |
| 02/18/2004 | EP1389183A1 Sulfonamide derivatives |
| 02/18/2004 | EP1389103A2 Synthesis and evaluation of novel phthalimide mimics as anti-angiogenic agents |
| 02/18/2004 | EP1216248B1 Triazolopyrimidine derivatives |
| 02/18/2004 | EP1178958B1 N-cyanomethyl amides as protease inhibitors |
| 02/18/2004 | EP0968192B1 Substituted tetrahydropyrimidine derivatives and their use as polymerization inhibitors for vinyl aromatic compounds |
| 02/18/2004 | CN1138780C Thienopyrimidines |
| 02/18/2004 | CN1138778C Bicyclic pyrimidines and bicyclic 3,4-dihydropyrimidines as inhibitors of cellular proliferation |
| 02/18/2004 | CN1138763C Di-or tri-fluoromethanesulfonyl anilide derivs, process for preparation of them and herbicides contg. them as active ingredient |
| 02/18/2004 | CN1138760C Preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and TACE inhibitors |
| 02/18/2004 | CN1138546C Certain 1,4,5-tri-substituted imidazole compounds useful as cytokine |
| 02/17/2004 | US6693196 Bis(2,4-diaminophenoxy)pyridines and pyrimidines |
| 02/17/2004 | US6693195 Process for preparing 4,6-dihydroxypyrimidine (DHP) |
| 02/17/2004 | US6693194 By reacting 4,6-dichloro-2-(methylthio)pyrimidine in an inert organic solvent with an alkali metal methoxide, transferring to an aqueous acid medium and oxidation; using the product to prepare 7-((4,6- |
| 02/17/2004 | US6693137 Sulphonamide derivatives |
| 02/17/2004 | US6693123 (4-(3-pyridylaminomethylene)-2-phenylbenzoyl)-n -methylmethionine, methyl ester for example; restenosis, hyperplasia |
| 02/17/2004 | US6693105 Using xanthinyl derivatives to reduce treatment induced toxicity; inhibiting cellular signaling through second messenger pathway; reducing cellular level of nonarachi-donate phosphatidic acid and diacylglycerol |
| 02/17/2004 | US6693103 1,2,3,4-tetrahydro-2-thioxo-quinolinyl and 1,2,3,4-tetrahydro-2-oxo-quinolinyl derivatives as progesterone receptor modulators |